Pivot

Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, March 26, 2024
Diabetic foot, Financial statement, PIN, Ulcer, Symposium, Sale, KNE, Pivot, Credit, Leg, SAWC, US FDA, Patent, FDA, Government, Food

WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial results.

Key Points: 
  • WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial results.
  • On December 20, 2023, Kane Biotech announced that it received a non-binding offer for its interest in STEM Animal Health.
  • Gross profit for the fourth quarter of 2023 was $398,234, an increase of 24% compared to $320,653 for the fourth quarter ended December 31, 2022.
  • Loss for the fourth quarter of 2023 was ($1,611,894), an increase of 92% compared to ($838,150) for the quarter ended December 31, 2022.

Teva UK and Closed Loop Medicine Announce Strategic Partnership to Advance Development of Personalised Medicines

Retrieved on: 
Tuesday, March 26, 2024
Software, Biotechnology, Pharmaceutical, Health, Medical Devices, Health Technology, Technology, Clinical Trials, Disease, Ulcerative colitis, Risk, Partnership, Patient, NHS, Mortality, Pivot, Pharmacotherapy, Investment, Clinical trial, Annual report, Inflammatory bowel disease, Teva, Therapy, Hypertension, Medicine, Pharmaceutical industry

Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.

Key Points: 
  • Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.
  • Under the agreement, Closed Loop Medicine – a leading TechBio company – and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicine’s proprietary software as a medical device (SaMD) technology platform which aims to advance the development of personalised medicines, improve drug efficacy and outcomes in patients with specific chronic disorders by combining dose-optimised drug therapy with digital care.
  • Dr Paul Goldsmith, Chief Medical Officer and Innovation Officer, Co-Founder and President of Closed Loop Medicine, said: “As clinicians, we know that dosing of drugs is a huge problem.
  • Being able to predict personalised dose levels could be transformational.”
    This strategic partnership harnesses Closed Loop Medicine’s proprietary SaMD and combines it with Teva’s pharmaceutical products creating the opportunity for digital companions to be prescribed alongside traditional therapeutics, enabling real-world data integration and improved effectiveness of innovative and known medicines.

NextUp Announces 2024 Executive Symposium & Forum

Retrieved on: 
Tuesday, March 26, 2024
Research, The Coca-Cola Company, HR, Business value, Aspen, Diversity, Doctor of Philosophy, IBM, Woman, Pivot, Accenture, Hain Celestial Group, Foodservice, Aspen Institute, Management

CHICAGO, March 26, 2024 /PRNewswire/ -- NextUp, the premier nonprofit dedicated to advancing all women in business, announced today that the 2024 Symposium & Forum, will take place Monday, June 3 through June 5 at the JW Marriott Washington, D.C. in our nation's capital. With over 300 attendees, this three-day conference activates the power of the NextUp community to drive impact and sustainable change.

Key Points: 
  • With over 300 attendees, this three-day conference activates the power of the NextUp community to drive impact and sustainable change.
  • This year's conference, made possible through the generous support of The Coca-Cola Company, will open with the inaugural NextUp Executive Symposium, which will bring together leading HR and business leaders in conversations about developing the next generation of leaders.
  • "As a founding partner of NextUp, we are thrilled to see its continued impact supporting the next generation of talent."
  • To learn more and register for the 2024 NextUp Symposium & Forum, visit nextupisnow.org/forum/.

In Landmark Deal, Walmart Invests in 19 Clean Energy Projects Across the Country with Pivot Energy

Retrieved on: 
Tuesday, March 26, 2024
Partnership, Pivot, Walmart, Solar energy, Environment, Renewable energy

DENVER, March 26, 2024 /PRNewswire/ -- Leading national renewable energy provider Pivot Energy announced today that Walmart is investing in 19 solar projects under development across the country including 15 community solar projects. The strategic tax equity investment will drive the construction, operation, and maintenance of a diverse solar project portfolio across five states – Illinois, Colorado, Maryland, Delaware, and California.

Key Points: 
  • DENVER, March 26, 2024 /PRNewswire/ -- Leading national renewable energy provider Pivot Energy announced today that Walmart is investing in 19 solar projects under development across the country including 15 community solar projects.
  • Walmart is investing in 19 solar projects nationwide, developed by Pivot Energy and enabling solar access to thousands.
  • Investing in solar energy projects developed by Pivot Energy distinguishes Walmart as a pioneer in renewable energy financing.
  • Through this landmark deal, Walmart and Pivot Energy are poised to accelerate the clean energy transition, paving the way for a more sustainable future and empowered communities.

Pivot Bio Shares Four Trends Driving Agriculture Forward

Retrieved on: 
Monday, March 18, 2024
Atmosphere, AG, Farmer, Farm, Face, CFO, Intelligence, Partnership, Agriculture, GPS, Food, Carbon, Pivot, Plant, Water, Weather, Summit, Machine learning, Soil, American Farmland Trust

BERKELEY, Calif., March 18, 2024 /PRNewswire/ -- Pivot Bio, a leading sustainable agriculture company, will send the company's CEO, CFO, Chief Innovation Officer and Chief Business Development Officer to San Francisco this week to meet with partners at the World Agri-Tech Innovation Summit, where leaders from across the industry will come together to explore new areas of collaboration. 

Key Points: 
  • Ahead of the Summit, Pivot Bio's CEO Chris Abbott the shared following four trends that the company will be watching closely at the conference.
  • Transforming the food system in a way that benefits growers, society and the planet will take partnerships and collaboration across sectors and industries.
  • Everyone is finally talking about capital efficiency again (thankfully), and the quickest way to grow efficiently is through partnerships.
  • Pivot Bio's role is to partner with our farmer customers who are driving solutions for an evolving food system using the latest technology and insights.

Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China

Retrieved on: 
Monday, February 26, 2024
FDA, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, Tardive dyskinesia, Chorea, VMAT2, Metabolism, EVP, Deuterium, Annual report, TEVA, Marketing, Teva, Partnership, HD, Quality of life, Food, Schizophrenia, Neurological disorder, DSM-IV codes, Globalization, Neuro, Prevalence, Happy Mood, Face, Anesthesia, Central nervous system disease, Pivot, Tongue, CNS, Psychiatry, Patient, Pain, Disease, Extremities, Research, Pharmaceutical industry

The partnership intends to increase patients’ access to Teva’s AUSTEDO, leveraging Nhwa’s leadership in China’s neuro-psychiatric health sector.

Key Points: 
  • The partnership intends to increase patients’ access to Teva’s AUSTEDO, leveraging Nhwa’s leadership in China’s neuro-psychiatric health sector.
  • “Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee, General Manager of Teva Greater China.
  • Chorea, one of the most striking physical manifestations of Huntington’s disease, is a neurological disorder that causes involuntary, random muscle movements.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd., founded in 1978, is a leading CNS company in China.

Pivotal Commware Promotes FWA Without Limits at 2024 Mobile World Congress Barcelona

Retrieved on: 
Thursday, February 22, 2024
Technology, Telecommunications, Mobile, Wireless, 5G, Networks, Hardware, Carriers and Services, IBMS, SLA, FWA, Multimedia, AI, MDU, Commercial, Mobile World Congress, High-pass filter, Economics, Pivot, Cable television

Pivotal Commware, global leader in 5G mmWave infrastructure products for the wireless edge, will promote its key role in the expansion of mmWave, “FWA Without Limits,” at the 2024 Mobile World Congress Barcelona on February 27 and 28.

Key Points: 
  • Pivotal Commware, global leader in 5G mmWave infrastructure products for the wireless edge, will promote its key role in the expansion of mmWave, “FWA Without Limits,” at the 2024 Mobile World Congress Barcelona on February 27 and 28.
  • It allows carriers to continue growing FWA net adds quarter over quarter without sacrificing valuable midband spectrum.
  • (Graphic: Business Wire)
    The success of FWA Without Limits relies in part on improvements to Pivotal’s product and service ecosystem as supported by deployment experience.
  • We call it the FWA one-two punch, which allows carriers to continue growing FWA net adds quarter over quarter without sacrificing valuable midband spectrum,” said Brian Deutsch, CEO of Pivotal Commware.

Niyam Announces Courtney Robertson as Senior Director, Strategic Accounts

Retrieved on: 
Thursday, March 7, 2024
Acquisition, Bangladesh Technical Education Board, Division, GSA, Food and Drug Administration, Federal Bureau of Investigation, National Institutes of Health, NIH, FEMA, FDA, DHS, Food, National security, Federation, Climate change, EPMD, NFIP, FBI, General Services Administration, LCCE, PMO, DFC, Information technology, Pivot, Bottled water

LEESBURG, Va., March 7, 2024 /PRNewswire/ -- Niyam IT , a leading solutions provider and a fast-growing IT services company delivering innovative solutions to the federal government, specifically for the National Security segment, today announced Courtney Robertson has been named the company's Senior Director, Strategic Accounts.

Key Points: 
  • LEESBURG, Va., March 7, 2024 /PRNewswire/ -- Niyam IT , a leading solutions provider and a fast-growing IT services company delivering innovative solutions to the federal government, specifically for the National Security segment, today announced Courtney Robertson has been named the company's Senior Director, Strategic Accounts.
  • "Courtney's experience with FEMA inflicting strategic change and spearheading successful modernization efforts will be invaluable," said Raj Parameswaran, President and COO, Niyam.
  • "I'm looking forward to the opportunity to work with Courtney again," said Suman Biswas, Founder and CEO, Niyam.
  • "I believe his addition to Niyam will put us on an upward growth trajectory for years to come and be a valued partner of FEMA ."

Radiance Solar and Pivot Energy to Complete Five Community Solar Projects in Illinois in 2024

Retrieved on: 
Monday, February 5, 2024
Commercial Building & Real Estate, Construction & Property, Professional Services, Environmental, Social and Governance (ESG), Other Energy, Utilities, Alternative Energy, Environment, Energy, Other Construction & Property, Sustainability, EPC, Partnership, Solar, Pivot, Carbon, Project management, Renewable energy

Radiance Solar and Pivot Energy are proud to announce their collaborative venture: a portfolio of five community solar projects in Illinois, with a combined capacity of 19 megawatts, slated for completion in 2024.

Key Points: 
  • Radiance Solar and Pivot Energy are proud to announce their collaborative venture: a portfolio of five community solar projects in Illinois, with a combined capacity of 19 megawatts, slated for completion in 2024.
  • Atlanta-based Radiance Solar, serving as the EPC partner, brings a wealth of experience to the project, having already completed over 10 community solar projects in Illinois.
  • Denver-based Pivot Energy, the owner of the facilities, is one of the leading community solar developers in Illinois and nationwide.
  • Matthew Dunham, VP of Project Management, Pivot Energy added "This partnership with Radiance Solar in developing these significant community solar projects showcases our joint dedication to providing sustainable, accessible clean energy solutions to communities in Illinois."

Teva Announces Intention to Divest API Business as Part of Pivot to Growth Strategy

Retrieved on: 
Wednesday, January 31, 2024
Biotechnology, Health, Science, Pharmaceutical, Research, Growth, Patient, Pivot, Medication, Annual report, TEVA, API, Biosimilar, Fine chemical

Teva announced today its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI".

Key Points: 
  • Teva announced today its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI".
  • TAPI is a global leader in the small-molecule API industry, with approximately 4,300 employees worldwide.
  • The intent to divest “TAPI” will allow Teva to maximize current and potential revenue streams, focusing on capital reallocation towards growth and innovation, and to better serve patients.
  • It will also allow the divested company to pursue new growth strategies, enabling it to maximize an array of opportunities in the $85 billion global API market.